<DOC>
	<DOCNO>NCT00259896</DOCNO>
	<brief_summary>This study placebo-controlled study healthy normal subject patient Type 2 Diabetes Mellitus ass level exenatide bloodstream give 7 day , assess impact medication various substance blood . Assessments include repeat blood sample monitoring side effect .</brief_summary>
	<brief_title>In-patient Study Patients With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Exenatide</mesh_term>
	<criteria>type 2 diabetes mellitus diagnose least three month must take either ( 1 ) medication diabetes ( 2 ) take metformin , sulfonylurea , metformin sulfonylurea must willing washout medication 14 day prior start study must bloodwork meet certain criterion ( example , total cholesterol &lt; 240 mg/dL ) must major illness diabetes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>66 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>exenatide</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>pharmacodynamics</keyword>
</DOC>